Pagenax Brolucizumab 120mg/ml Injection

Pagenax Brolucizumab 120mg/ml Injection is an advanced ophthalmic medication containing Brolucizumab, an anti-VEGF (vascular endothelial growth factor) therapy used for treating serious retinal and eye disorders. It is mainly prescribed for patients suffering from Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and other retinal vascular diseases that may lead to vision loss.

Brolucizumab works by blocking abnormal blood vessel growth and fluid leakage inside the retina, helping improve or stabilize vision. This injection is administered directly into the eye by a qualified ophthalmologist under sterile medical conditions.

Contact Details for Orders

• 💬 WhatsApp: +91 9730316395
• 📞 Phone: +91 9730316395
• 📧 Email: info@globmedindia.com
• 🌐 Website: globmedsindia.com

Composition and Content

• Brand Name: Pagenax Brolucizumab 120mg/ml Injection
• Generic Name: Brolucizumab
• Strength: 120 mg/ml
• Dosage Form: Injection
• Drug Category: Anti-VEGF Ophthalmic Medicine
• Administration Route: Intravitreal Injection

Uses and Treatments

Pagenax Brolucizumab 120mg/ml Injection is used for:

• Wet Age-Related Macular Degeneration (AMD)
• Diabetic Macular Edema (DME)
• Retinal Vein Occlusion (RVO)
• Retinal Swelling and Macular Disorders
• Vision-threatening retinal vascular diseases

Brolucizumab reduces retinal swelling and prevents abnormal blood vessel leakage that can damage vision.

How to Use

• Administered only by a trained ophthalmologist.
• Given as an intravitreal injection directly into the eye.
• Performed under sterile clinical conditions.
• Regular eye examinations may be required during treatment.
• Treatment intervals depend on the patient’s response and retinal condition.

Do not self-administer this injection.

Dosage Information

Dosage depends on:

• Type of retinal disease
• Severity of vision condition
• Patient response to therapy
• Ophthalmologist recommendation

Typical dosage:

• Intravitreal injection at scheduled intervals as prescribed by the eye specialist.

Regular monitoring is important for best treatment outcomes.

Advantages of Pagenax Brolucizumab 120mg/ml Injection

• Helps improve or stabilize vision
• Reduces retinal swelling and fluid leakage
• Advanced anti-VEGF therapy
• Longer treatment intervals in some patients
• Effective for serious retinal disorders
• Helps manage progressive eye diseases

Possible Side Effects

Common side effects may include:

• Eye redness
• Eye pain
• Blurred vision
• Increased eye pressure
• Floaters
• Eye inflammation
• Light sensitivity

Seek immediate medical care if severe eye pain, sudden vision loss, or signs of infection occur.

Storage Conditions

• Store refrigerated between 2°C to 8°C.
• Do not freeze.
• Protect from direct sunlight.
• Keep in original packaging.
• Keep out of reach of children.

Alternative Indian Brands for Brolucizumab Injection

Alternative brands may include:

• Beovu
• BroluCare
• Broliz
• Retizumab

Availability may vary according to prescription requirements and export permissions.

Why Choose GlobMedIndia?

• Trusted exporter of specialty medicines
• Affordable international pricing
• Genuine pharmaceutical products
• Secure cold-chain packaging
• Fast worldwide delivery
• Professional customer assistance
• Reliable medicine export services

Visit: GlobMedIndia Official Website

Buy Now Pagenax Brolucizumab 120mg/ml Injection online from GlobMedIndia – The Trusted Medicine Exporter for specialty and ophthalmic medicines. 

Get fast, safe & secure delivery across Saudi Arabia including Riyadh, Jeddah, Mecca, Medina, Taif, Tabuk, Abha, and Dammam.Pagenax Brolucizumab 120mg/ml Injection is widely used for Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and retinal vascular disorders. GlobMedIndia supplies genuine ophthalmic medicines with secure international shipping and affordable export pricing.